InstalabLoading...
InstalabLoading...
Your gut bacteria do not just digest food. They chemically rewire the bile acids your liver releases, producing a parade of modified molecules that circulate back through your body. 3-Dehydrocholic acid is one of those bacterial handprints, and tracking it gives a window into a part of your biology that standard liver and metabolic labs cannot see.
This is a research-grade stool measurement, not a clinical diagnostic. It is most useful as one input within a broader bile acid panel, where the pattern of values matters more than any single number. If you want to understand the conversation between your liver, your bile, and your microbiome, this is one of the molecules carrying the message.
Bile acids start in your liver, made from cholesterol. They flow into the gut to help you absorb fat, then most are reabsorbed and recycled. Along the way, gut bacteria modify them, swapping hydroxyl groups (an -OH chemical group) for keto groups (a C=O chemical group) and producing a family of so-called oxidized or dehydro bile acids. 3-DHC (3-dehydrocholic acid) is one of these microbial products.
Specifically, 3-DHC appears as a downstream oxidation product of deoxycholic acid (DCA), itself a secondary bile acid created when gut bacteria strip a hydroxyl group from primary bile acids. The presence of 3-DHC in stool reflects the activity of bacterial enzymes (hydroxysteroid dehydrogenases) that work on the bile acid pool. Higher levels signal more aggressive microbial reworking of bile, not necessarily more bile acid production by your liver.
There is also a synthetic version of dehydrocholic acid (called triketocholanoic acid or Tri-K-C, a fully oxidized form of cholic acid) used historically as a hydrocholeretic drug to stimulate bile flow. That pharmaceutical compound does not occur naturally in human bile. The 3-DHC measured in stool is the microbially generated form, which is biologically distinct.
The strongest direct evidence linking 3-DHC to disease comes from research on fatty liver. In a study of fecal bile acids and the gut microbiome across stages of nonalcoholic fatty liver disease (NAFLD) and its more aggressive form (NASH, nonalcoholic steatohepatitis), 3-DHC and other DCA-derived oxidized bile acids increased with worsening disease activity and higher fibrosis stage. This rose alongside increases in DCA itself and in bacterial genes responsible for bile acid transformation.
What this means for you: an elevated 3-DHC, especially when paired with elevated DCA, is a signal that your gut bacteria are tilted toward the kind of bile acid metabolism associated with liver injury. This is correlational, not causal, and DCA itself appears to be the more clinically meaningful driver. But 3-DHC adds texture to the picture by confirming that the microbial machinery doing the transformation is active.
There is no direct evidence linking 3-DHC stool levels to cardiovascular events, cancer, or all-cause mortality. The bile acid family as a whole has been studied in coronary artery disease, kidney disease, heart failure, and colorectal cancer, but those associations are driven primarily by other species (especially DCA, lithocholic acid, and primary bile acids in serum), not by 3-DHC. Treat this marker as one descriptor of your bile acid profile, not as a standalone risk score.
There are no standardized clinical reference ranges for 3-dehydrocholic acid. It is reported as a research-derived value within stool bile acid panels, typically in nanograms per gram of stool. Different laboratories use different extraction and detection methods, so absolute numbers are not comparable across labs.
What this means for you: do not anchor on a single number. The most useful information comes from your value within the context of the rest of your stool bile acid profile (especially DCA and total secondary bile acids), and from how your number changes over time when measured by the same lab using the same method.
Stool bile acid composition varies day to day based on what you ate, your stool transit time, and short-term shifts in your microbiome. A single elevated reading is not a diagnosis. A trend across two or three samples taken weeks apart is far more informative than any one snapshot.
Get a baseline, then retest in 3 to 6 months if you are making changes to diet, fiber intake, or your microbiome (probiotics, prebiotics, antibiotic exposure). After that, annual retesting is reasonable for most people who use this as part of a longevity workup. If you are tracking liver disease activity alongside hepatology care, more frequent testing may make sense in coordination with your specialist.
Because 3-DHC alone does not diagnose any condition, an unusual value should trigger a wider workup rather than a panic. The most informative companion data points are the rest of the stool bile acid panel (especially DCA, secondary bile acid totals, and the secondary-to-primary ratio), liver enzymes (ALT (alanine aminotransferase), AST (aspartate aminotransferase), GGT (gamma-glutamyl transferase)), a fasting metabolic panel, and imaging or elastography (a scan that measures liver stiffness) if liver fibrosis is a concern.
If your 3-DHC and DCA are both elevated, and you have other markers of metabolic dysfunction (elevated liver enzymes, high triglycerides, or central adiposity), that pattern is worth investigating with a hepatologist or a physician trained in metabolic medicine. If your bile acid panel looks unusual but your liver enzymes and metabolic labs are clean, the finding is more exploratory and is best interpreted as part of a broader gut and microbiome assessment rather than as a standalone diagnosis.
3-Dehydrocholic Acid is best interpreted alongside these tests.